BioCentury | Jan 23, 2021
Management Tracks

Yale’s Fuchs joins Genentech, Roche; plus Lineage’s Roberts jumps on Longboard as CFO and Avidity, Xalud, AVM, Novavax

...replaces Theresa Deisher, AVM’s founder, who is chairman, president and CSO. Cox was previously CEO of Protein Sciences Corp....
BioCentury | Feb 19, 2020
Product Development

COVID-19 update: Sanofi enters vaccine race with BARDA collaboration; plus J&J-BARDA expansion, clinical and diagnostic advances, and more

...an approved quadrivalent seasonal flu vaccine developed with the technology, via its 2017 acquisition of Protein Sciences Corp....
...to test a preclinical severe acute respiratory syndrome (SARS) vaccine that had been developed by Protein Sciences...
BioCentury | Sep 27, 2019
Politics, Policy & Law

Trump administration to modernize flu vaccines via government buying power

...Flublok, received FDA approval in 2013. The Sanofi Pasteur division of Sanofi (Euronext:SAN; NASDAQ:SNY) acquired Protein Sciences...
...does not qualify as a domestically produced vaccine. Prior to Sanofi’s acquisition of the company, Protein Sciences...
BioCentury | Jun 29, 2018
Company News

AbbVie, Calibr to develop universal CAR T therapies

...their dramatic impact has been limited to blood cancers. According to Travis Young, director of protein sciences...
BioCentury | Jun 25, 2018
Company News

AbbVie, Calibr to develop universal CAR T therapies

...their dramatic impact has been limited to blood cancers. According to Travis Young, director of protein sciences...
BioCentury | Jul 14, 2017
Company News

Sanofi acquiring vaccines company Protein Sciences

...Sanofi (Euronext:SAN; NYSE:SNY) said it will acquire vaccines play Protein Sciences Corp. (Meriden, Conn.). The deal gives Sanofi...
...The deal gives Sanofi influenza vaccine Flublok Quadrivalent , which FDA approved in October 2016. Protein Sciences'...
...in total sales. Protein Sciences Corp. , Meriden, Conn. Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Business: Infectious Chris Lieu Flublok Quadrivalent Protein Sciences Corp. Sanofi...
BioCentury | Jul 11, 2017
Company News

Sanofi acquiring vaccines company Protein Sciences

...Sanofi (Euronext:SAN; NYSE:SNY) said it will acquire vaccines play Protein Sciences Corp. (Meriden, Conn.). The deal gives Sanofi...
...The deal gives Sanofi influenza vaccine Flublok Quadrivalent , which FDA approved in October 2016. Protein Sciences'...
...of the pharma's Sanofi Pasteur vaccines unit's €4.6 billion ($5.2 billion) in total sales. Chris Lieu Flublok Quadrivalent Protein Sciences Corp. Sanofi...
BioCentury | Dec 22, 2016
Product R&D

Fever pace for Zika

...hVIVO plc (LSE:HVO); Seek Ltd. Undisclosed vaccine Preclinical Novavax Inc. ( NASDAQ:NVAX) Undisclosed vaccine Preclinical Protein Sciences Corp....
BioCentury | Dec 3, 2016
Company News

Management tracks

...that target dysregulated growth factors, named Alan Buckler CSO. He was VP of cell and protein sciences...
BioCentury | Oct 17, 2016
Clinical News

Flublok Quadrivalent regulatory update

...FDA approved an sBLA from Protein Sciences for Flublok Quadrivalent to prevent 2 influenza A subtype viruses...
...insect cells. The company markets Flublok, a trivalent formulation of the vaccine, in the U.S. Protein Sciences Corp....
Items per page:
1 - 10 of 106
BioCentury | Jan 23, 2021
Management Tracks

Yale’s Fuchs joins Genentech, Roche; plus Lineage’s Roberts jumps on Longboard as CFO and Avidity, Xalud, AVM, Novavax

...replaces Theresa Deisher, AVM’s founder, who is chairman, president and CSO. Cox was previously CEO of Protein Sciences Corp....
BioCentury | Feb 19, 2020
Product Development

COVID-19 update: Sanofi enters vaccine race with BARDA collaboration; plus J&J-BARDA expansion, clinical and diagnostic advances, and more

...an approved quadrivalent seasonal flu vaccine developed with the technology, via its 2017 acquisition of Protein Sciences Corp....
...to test a preclinical severe acute respiratory syndrome (SARS) vaccine that had been developed by Protein Sciences...
BioCentury | Sep 27, 2019
Politics, Policy & Law

Trump administration to modernize flu vaccines via government buying power

...Flublok, received FDA approval in 2013. The Sanofi Pasteur division of Sanofi (Euronext:SAN; NASDAQ:SNY) acquired Protein Sciences...
...does not qualify as a domestically produced vaccine. Prior to Sanofi’s acquisition of the company, Protein Sciences...
BioCentury | Jun 29, 2018
Company News

AbbVie, Calibr to develop universal CAR T therapies

...their dramatic impact has been limited to blood cancers. According to Travis Young, director of protein sciences...
BioCentury | Jun 25, 2018
Company News

AbbVie, Calibr to develop universal CAR T therapies

...their dramatic impact has been limited to blood cancers. According to Travis Young, director of protein sciences...
BioCentury | Jul 14, 2017
Company News

Sanofi acquiring vaccines company Protein Sciences

...Sanofi (Euronext:SAN; NYSE:SNY) said it will acquire vaccines play Protein Sciences Corp. (Meriden, Conn.). The deal gives Sanofi...
...The deal gives Sanofi influenza vaccine Flublok Quadrivalent , which FDA approved in October 2016. Protein Sciences'...
...in total sales. Protein Sciences Corp. , Meriden, Conn. Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Business: Infectious Chris Lieu Flublok Quadrivalent Protein Sciences Corp. Sanofi...
BioCentury | Jul 11, 2017
Company News

Sanofi acquiring vaccines company Protein Sciences

...Sanofi (Euronext:SAN; NYSE:SNY) said it will acquire vaccines play Protein Sciences Corp. (Meriden, Conn.). The deal gives Sanofi...
...The deal gives Sanofi influenza vaccine Flublok Quadrivalent , which FDA approved in October 2016. Protein Sciences'...
...of the pharma's Sanofi Pasteur vaccines unit's €4.6 billion ($5.2 billion) in total sales. Chris Lieu Flublok Quadrivalent Protein Sciences Corp. Sanofi...
BioCentury | Dec 22, 2016
Product R&D

Fever pace for Zika

...hVIVO plc (LSE:HVO); Seek Ltd. Undisclosed vaccine Preclinical Novavax Inc. ( NASDAQ:NVAX) Undisclosed vaccine Preclinical Protein Sciences Corp....
BioCentury | Dec 3, 2016
Company News

Management tracks

...that target dysregulated growth factors, named Alan Buckler CSO. He was VP of cell and protein sciences...
BioCentury | Oct 17, 2016
Clinical News

Flublok Quadrivalent regulatory update

...FDA approved an sBLA from Protein Sciences for Flublok Quadrivalent to prevent 2 influenza A subtype viruses...
...insect cells. The company markets Flublok, a trivalent formulation of the vaccine, in the U.S. Protein Sciences Corp....
Items per page:
1 - 10 of 106